Company news

GSK plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NMPA approves Vocabria+Rekambys in China

October 26, 2023

New data for Arexvy, GSK’s RSV vaccine

October 25, 2023

Jemperli plus chemotherapy positive CHMP opinion

October 16, 2023

Zantac (ranitidine) litigation

October 11, 2023

GSK and Zhifei announce vaccine partnership

October 9, 2023

GSK RSV vaccine for older adults approved in Japan

September 25, 2023

Apretude for PrEP receives EMA approval

September 19, 2023

FDA approves Ojjaara (momelotinib)

September 18, 2023

Momelotinib filing accepted in Japan

September 11, 2023

GSK’s Nucala CRSwNP submission accepted in Japan

September 1, 2023

Shingrix data demonstrate 100% efficacy in China

August 23, 2023

FDA approves new use for Jemperli plus chemo

July 31, 2023

Cabotegravir LA for PrEP receives positive CHMP

July 24, 2023

GSK completes acquisition of BELLUS Health

June 28, 2023

FDA Fast Track for Gonorrhoea Vaccine Candidate

June 27, 2023

Shingrix approved in Japan for adults 18 and over

June 26, 2023

GSK daprodustat gains positive EMA CHMP opinion

June 26, 2023

GSK’s Arexvy recommended by ACIP

June 22, 2023

Season two data for GSK Arexvy RSV OA vaccine

June 21, 2023

Extension of FDA review period for momelotinib

June 16, 2023

EU authorisation of GSK’s RSV vaccine Arexvy

June 7, 2023

GSK receives US FDA file acceptance for Jemperli

June 6, 2023

MenABCWY vaccine preliminary phase III results

May 12, 2023

Statement: Zantac Litigation Update BC Canada

May 12, 2023

US FDA approves GSK’s RSV vaccine for older adults

May 3, 2023

GSK RSV OA vaccine gains positive EMA CHMP opinion

April 27, 2023

EMA validates Jemperli filing for new indication

April 25, 2023

GSK reaches agreement to acquire BELLUS Health Inc

April 18, 2023

Gepotidacin positive phase III data

April 17, 2023

Positive phase III RUBY results for Jemperli

March 28, 2023

Publication of 2023 AGM Notice

March 27, 2023

Positive phase III results for MenABCWY vaccine

March 14, 2023

Nucala NDA accepted for review in China

March 14, 2023

GSK Annual Report 2022 on Form 20-F

March 10, 2023

GSK publishes Annual Report 2022

March 10, 2023

FDA Ad Com votes to support GSK RSV OA vaccine

March 2, 2023

ViiV Healthcare announces Cabenuva positive data

February 23, 2023

NEJM publishes GSK RSV OA vaccine candidate trial

February 16, 2023

Jemperli full FDA approval following GARNET trial

February 10, 2023

Jemperli FDA ODAC positive outcome

February 10, 2023

Daprodustat approved by US FDA for anaemia of CKD

February 2, 2023

Benlysta granted Orphan Drug Designation by US FDA

February 1, 2023

Board and Committee Changes

December 15, 2022

Jemperli positive trial in endometrial cancer

December 2, 2022

EMA file accepted for momelotinib

December 2, 2022

GSK publishes provisional 2023 dividend dates

November 24, 2022

Blenrep US Update

November 22, 2022

GSK Update: Zejula 2L in US

November 11, 2022

Sanofi-GSK COVID booster vaccine approved by EU

November 10, 2022

DREAMM-3 phase III trial for Blenrep

November 7, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 181 decks. Every deck is listed under its year.